Reduction of carboplatin induced emesis by ondansetron.

Ondansetron is a selective 5-HT3 antagonist with significant antiemetic properties in patients receiving cytotoxic chemotherapy. Patients who had suffered severe vomiting on carboplatin alone (23 patients with ovarian carcinoma) or in combination (two patients with testicular cancer) despite intensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Harvey, V. J., Evans, B. D., Mitchell, P. L., Mak, D., Neave, L. M., Langley, G. B., Dickson, D. S.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1991
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972533/
https://www.ncbi.nlm.nih.gov/pubmed/1829954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972533/
https://www.ncbi.nlm.nih.gov/pubmed/1829954

Ejemplares similares